Literature DB >> 17667638

The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway.

Anja S Lindman1, Marit B Veierød, Jan I Pedersen, Aage Tverdal, Inger Njølstad, Randi Selmer.   

Abstract

AIMS: To evaluate the predictive accuracy of the Systematic Coronary Risk Evaluation (SCORE) project high-risk function in Norway. METHODS AND
RESULTS: We included 57 229 individuals screened in 1985-1992 from two population-based surveys in Norway (age groups 40-49, 50-59, and 60-69 years). The data have been linked to the Norwegian Cause of Death Registry. The SCORE high-risk algorithm for the prediction of 10-year cardiovascular disease (CVD) mortality was applied, and the risk factors entered into the model were age, sex, total cholesterol, systolic blood pressure, and smoking (yes/no). The number of expected events estimated by the SCORE model (E) was compared with the observed numbers (O). The SCORE low-risk algorithm was studied for comparison. In men, the observed number of CVD deaths was 718, compared with 1464 estimated by the SCORE high-risk function (O/E ratios 0.53, 0.53 and 0.45, for age groups 40-49, 50-59 and 60-69, respectively). In women, the observed and expected numbers were 226 and 547. The O/E ratios decreased with age (ratios 0.60, 0.45 and 0.37, respectively), i.e. the overestimation increased with age. The low-risk function predicted reasonably well for men (ratios 0.85, 0.92 and 0.79, respectively), whereas an overestimation was found for women aged 50-59 and 60-69 years (ratios 0.69 and 0.56, respectively).
CONCLUSION: The SCORE high-risk model overestimated the number of CVD deaths in Norway. Before implementation in clinical practice, proper adjustments to national levels are required.

Entities:  

Mesh:

Year:  2007        PMID: 17667638     DOI: 10.1097/HJR.0b013e328011490a

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  14 in total

Review 1.  Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk.

Authors:  Morton Leibowitz; Chandra Cohen-Stavi; Sanjay Basu; Ran D Balicer
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

2.  Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.

Authors:  Halfdan Petursson; Johann A Sigurdsson; Calle Bengtsson; Tom I L Nilsen; Linn Getz
Journal:  J Eval Clin Pract       Date:  2011-09-25       Impact factor: 2.431

3.  Does present use of cardiovascular medication reflect elevated cardiovascular risk scores estimated ten years ago? A population based longitudinal observational study.

Authors:  Mette Brekke; Jørund Straand
Journal:  BMC Public Health       Date:  2011-03-02       Impact factor: 3.295

4.  Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.

Authors:  Eliseo Guallar; José R Banegas; Elena Blasco-Colmenares; F Javier Jiménez; Jean Dallongeville; Julian P Halcox; Claudio Borghi; Elvira L Massó-González; Mónica Tafalla; Joep Perk; Guy De Backer; Philippe G Steg; Fernando Rodríguez-Artalejo
Journal:  BMC Public Health       Date:  2011-09-18       Impact factor: 3.295

5.  The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.

Authors:  Martin B Mortensen; Shoaib Afzal; Børge G Nordestgaard; Erling Falk
Journal:  Eur Heart J       Date:  2015-06-16       Impact factor: 29.983

6.  Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 population.

Authors:  Halfdan Petursson; Linn Getz; Johann A Sigurdsson; Irene Hetlevik
Journal:  BMC Fam Pract       Date:  2009-10-30       Impact factor: 2.497

7.  Agreement between the SCORE and D'Agostino Scales for the classification of high cardiovascular risk in sedentary spanish patients.

Authors:  Manuel A Gómez-Marcos; Gonzalo Grandes; José A Iglesias-Valiente; Alvaro Sánchez; Imanol Montoya; Luis García-Ortiz
Journal:  Int J Environ Res Public Health       Date:  2009-11-11       Impact factor: 3.390

8.  Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.

Authors:  Helle Wallach-Kildemoes; Finn Diderichsen; Allan Krasnik; Theis Lange; Morten Andersen
Journal:  BMC Public Health       Date:  2012-08-04       Impact factor: 3.295

9.  Construction of an odds model of coronary heart disease using published information: the Cardiovascular Health Improvement Model (CHIME).

Authors:  Christopher J Martin; Paul Taylor; Henry W W Potts
Journal:  BMC Med Inform Decis Mak       Date:  2008-10-31       Impact factor: 2.796

10.  SCORE performance in Central and Eastern Europe and former Soviet Union: MONICA and HAPIEE results.

Authors:  Olga Vikhireva; Andrzej Pajak; Grazyna Broda; Sofia Malyutina; Abdonas Tamosiunas; Ruzena Kubinova; Galina Simonova; Zdena Skodova; Martin Bobak; Hynek Pikhart
Journal:  Eur Heart J       Date:  2013-06-20       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.